The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
National Cancer Data Base report on malignant paragangliomas of the head and neck
Open accessAbstract
BACKGROUND: Malignant paragangliomas of the head and neck are rare, with previous reports limited to nine or fewer patients. The current review included 59 cases extracted from the National Cancer Data Base that were diagnosed between 1985–1996. METHODS: The primary criterion for inclusion in the current study was verified metastatic spread from a paraganglioma of the head and neck. Patterns of presentation and treatment as well as clinically relevant associations were demonstrated in contingency tables. Relative survival was used for analysis of outcome. RESULTS: The average patient age at presentation was 44 years, and gender distribution was equivalent. Metastases were confined to regional lymph nodes in the majority of cases (68.6%), with carotid body tumors found to have an even higher rate of regional confinement (93.8%). Surgery was the most common treatment (76.3%). The use of adjuvant irradiation for regionally confined disease increased across time, from 27% (1985–1990) to 46% (1991–1996). The 5‐year relative survival rate was 59.5% (76.8% for regionally confined carcinoma and 11.8% for distant metastasis). Among patients who were followed until death, those treated with adjuvant irradiation had a longer median survival (45 months) compared with those patients who were treated with surgery alone (12 months). CONCLUSIONS: Malignant paraganglioma represents metastatic spread of a tumor type that, when restricted to the site of origin, is considered benign. Metastases from malignant paragangliomas of the head and neck usually are regionally confined. The primary management of a recognized malignancy should be directed toward complete surgical removal of the primary tumor and regional lymph nodes. Postoperative irradiation may be beneficial in slowing the progression of residual disease. Cancer 2002;94:730–7. © 2002 American Cancer Society. DOI 10.1002/cncr.10252
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Firminger, H. I. (1968) · Armed Forces Institute of Pathology eBooks · Cited by 3,044
Beahrs, O. H., & Henson, D. E. (1992) · Medical Entomology and Zoology · Cited by 2,460
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Friedman, E., & Friedman, C. D. (1978) · International Journal of Oral Surgery · doi:10.1016/s0300-9785(78)80097-0 · Cited by 672
The National Cancer Data Base Report on Cancer of the Head and Neck
Hoffman, H. T., Karnell, L. H., Funk, G. F., Robinson, R. A., & Menck, H. R. (1998) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.124.9.951 · Cited by 368
Self-citationManolidis, S., Shohet, J. A., Jackson, C. G., & Glasscock, M. E. (1999) · The Laryngoscope · doi:10.1097/00005537-199901000-00007 · Cited by 159
Manual for Staging of Cancer, 3rd edition
Beahrs, O. H., Henson, D. E., Hutter, R. V. P., & Myers, M. H. (1988) · American Journal of Clinical Oncology · doi:10.1097/00000421-198812000-00027 · Cited by 147
Cited by
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
Bilimoria, K. Y., Stewart, A. K., Winchester, D. P., & Ko, C. Y. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9747-3 · Cited by 1,851
Ayala-Ramirez, M., Feng, L., Johnson, M. M., Ejaz, S., Habra, M. A., Rich, T., Busaidy, N., Cote, G. J., Perrier, N., Phan, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1946 · Cited by 428
Bardella, C., Pollard, P. J., & Tomlinson, I. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.07.003 · Cited by 395
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0170 · Cited by 355
Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years
Hamidi, O., Young, W. F., Iñiguez-Ariza, N. M., Kittah, N. E., Gruber, L., Bancos, C., Tamhane, S., & Bancos, I. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00992 · Cited by 316
Metadata
- Authors
- Lee, J. H., Barich, F., Karnell, L. H., Robinson, R. A., Zhen, W. K., Gantz, B. J., Hoffman, H. T., & American College of Surgeons Commission on Cancer and the American Cancer Society
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-01-31
- Volume
- 94
- Issue
- 3
- Pages
- 730-737
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1982777876
- Cited by
- 427
- References
- 8
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: National Cancer Data Base report on malignant paragangliomas of the head and neck. https://app.cochat.ai/papers/10.1002/cncr.10252
- The paper
- Lee, J. H., Barich, F., Karnell, L. H., Robinson, R. A., Zhen, W. K., Gantz, B. J., Hoffman, H. T., & American College of Surgeons Commission on Cancer and the American Cancer Society. (2002). National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. https://doi.org/10.1002/cncr.10252
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.